The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.

På svenska

Author

  • Tobias Nordström
  • Andrew Vickers
  • Melissa Assel
  • Hans Lilja
  • Henrik Grönberg
  • Martin Eklund

Summary, in English

The four-kallikrein panel and the Prostate Health Index (PHI) have been shown to improve prediction of prostate cancer (PCa) compared with prostate-specific antigen (PSA). No comparison of the four-kallikrein panel and PHI has been presented.

Publishing year

2015

Language

English

Pages

139-146

Publication/Series

European Urology

Volume

68

Issue

1

Document type

Journal article

Publisher

Elsevier

Topic

  • Urology and Nephrology

Status

Published

Research group

  • Clinical Chemistry, Malmö

ISBN/ISSN/Other

  • ISSN: 1873-7560